|
Name |
(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2S)-tetrahydro-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester
|
| Molecular Formula | C24H36O4 | |
| IUPAC Name* |
[3,7-dimethyl-8-[2-(6-oxooxan-2-yl)ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl]2-methylbutanoate
|
|
| SMILES |
CCC(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CCCC(=O)O3)C21
|
|
| InChI |
InChI=1S/C24H36O4/c1-5-16(3)24(26)28-21-14-15(2)13-18-10-9-17(4)20(23(18)21)12-11-19-7-6-8-22(25)27-19/h9-10,13,15-17,19-21,23H,5-8,11-12,14H2,1-4H3/t15-,16-,17-,19-,20-,21-,23-/m0/s1
|
|
| InChIKey |
ABCOWPXGNWZMNY-OCAGQIGWSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 388.55 | ALogp: | 5.2 |
| HBD: | 0 | HBA: | 4 |
| Rotatable Bonds: | 6 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 52.6 | Aromatic Rings: | 3 |
| Heavy Atoms: | 28 | QED Weighted: | 0.564 |
| Caco-2 Permeability: | -4.786 | MDCK Permeability: | 0.00002260 |
| Pgp-inhibitor: | 0.999 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.019 | 20% Bioavailability (F20%): | 0.935 |
| 30% Bioavailability (F30%): | 0.994 |
| Blood-Brain-Barrier Penetration (BBB): | 0.704 | Plasma Protein Binding (PPB): | 97.02% |
| Volume Distribution (VD): | 0.837 | Fu: | 1.99% |
| CYP1A2-inhibitor: | 0.038 | CYP1A2-substrate: | 0.071 |
| CYP2C19-inhibitor: | 0.043 | CYP2C19-substrate: | 0.788 |
| CYP2C9-inhibitor: | 0.093 | CYP2C9-substrate: | 0.262 |
| CYP2D6-inhibitor: | 0.017 | CYP2D6-substrate: | 0.235 |
| CYP3A4-inhibitor: | 0.92 | CYP3A4-substrate: | 0.736 |
| Clearance (CL): | 15.519 | Half-life (T1/2): | 0.16 |
| hERG Blockers: | 0.545 | Human Hepatotoxicity (H-HT): | 0.971 |
| Drug-inuced Liver Injury (DILI): | 0.073 | AMES Toxicity: | 0.01 |
| Rat Oral Acute Toxicity: | 0.242 | Maximum Recommended Daily Dose: | 0.947 |
| Skin Sensitization: | 0.963 | Carcinogencity: | 0.55 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.014 |
| Respiratory Toxicity: | 0.81 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002580 | ![]() |
0.775 | D06WTZ | ![]() |
0.775 | ||
| ENC002912 | ![]() |
0.733 | D0H0ND | ![]() |
0.600 | ||
| ENC000662 | ![]() |
0.660 | D02RQU | ![]() |
0.459 | ||
| ENC006006 | ![]() |
0.528 | D04QNO | ![]() |
0.252 | ||
| ENC001935 | ![]() |
0.495 | D0Y7IU | ![]() |
0.252 | ||
| ENC002332 | ![]() |
0.474 | D0D2TN | ![]() |
0.248 | ||
| ENC001102 | ![]() |
0.427 | D03SXE | ![]() |
0.232 | ||
| ENC006008 | ![]() |
0.333 | D0K7HU | ![]() |
0.230 | ||
| ENC000525 | ![]() |
0.313 | D09WYX | ![]() |
0.230 | ||
| ENC004385 | ![]() |
0.310 | D0CZ1Q | ![]() |
0.228 | ||